Fueled by a recent $42 million financing, Ivenix Inc. (Amesbury, Mass.) has a new CEO in its driver's seat ready to steer the company toward commercialization of its infusion pump management system. The company said it has made "substantial progress" in product development since it raised the funds in September, led by new investor Wuxi Healthcare Ventures, and is now preparing for regulatory filings to enter the $6 billion global infusion market. Stuart Randle, the new CEO of Ivenix, was previously president and CEO of GI Dynamics Inc. (Lexington, Mass.).

In a move that would give Nuvasive Inc. (San Diego), access to the pediatric deformity market, the company has entered into an agreement to acquire Ellipse Technologies Inc. (Aliso Viejo, Calif.) for $380 million with a potential $30 million milestone, payable in 2017. The deal is expected to close at the end of February.